Effect of β-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic β-lactamase producing bacteria

This publication has 14 references indexed in Scilit:

• In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with β-lactamase inhibitors
  Journal of Antimicrobial Chemotherapy, 1986
• In vitro activity and disk susceptibility of timentin: current status
  The American Journal of Medicine, 1985
• In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and β-lactamase studies
  Diagnostic Microbiology and Infectious Disease, 1985
• Activity of β-lactamase inhibitors in combination with new β-lactam antibiotics against resistant gram-negative organisms
  Diagnostic Microbiology and Infectious Disease, 1984
• Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group
  Antimicrobial Agents and Chemotherapy, 1984
• In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates
  Antimicrobial Agents and Chemotherapy, 1984
• Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production
  Antimicrobial Agents and Chemotherapy, 1982
• Antimicrobial Activity of Desacetylcefotaxime Alone and in Combination with Cefotaxime: Evidence of Synergy
  Clinical Infectious Diseases, 1982
• Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin
  Antimicrobial Agents and Chemotherapy, 1980
• CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of Beta-Lactams: Initial Bacteriological Characterization
  Antimicrobial Agents and Chemotherapy, 1978